Analysts have set 12-month price targets for Eton Pharmaceuticals, revealing an average target of $24.4, a high estimate of $33.00, and a low estimate of $17.00. Marking an increase of 22.0%, the ...
Management to Hold Investor Day Conference Call Today at 10:00am ETReported record product revenue of $11.6 million in Q4 2024, an increase of ...
7d
Company’s patented desmopressin oral solution successfully passed pivotal bioequivalence study -- Company expects to submit New Drug ...
DEER PARK, Ill., March 03, 2025 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (“Eton” or the “Company”) (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and ...
Eton Pharmaceuticals Inc is a United States based ... This under-the-radar company could surge 200%+ as major market shifts unfold. Click here for urgent details. Mar 2021 HC Wainwright & Co ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback